🌾 Dhanuka Agritech Q2 FY2025-26 Results: Profit Drops 20% YoY Amid Weather Challenges, Management Confident of H2 Recovery
🔹 Introduction
India’s leading agrochemical company Dhanuka Agritech Ltd. has released its Q2 FY2025-26 financial results, highlighting a challenging quarter impacted by erratic rainfall and lower pest incidence across key farming regions.
While the company reported a year-on-year (YoY) decline in revenue and profit, sequential growth compared to Q1 FY2025-26 shows that demand is beginning to normalize. The management remains confident about a stronger performance in the second half of FY 2025-26, backed by new product launches and expanding manufacturing capacity.
💰 Dhanuka Agritech Financial Performance Snapshot
| Particulars (₹ crore) | Q2 FY2025-26 | Q1 FY2025-26 | Q2 FY2024-25 |
|---|---|---|---|
| Revenue from Operations | 598.25 | 528.29 | 654.28 |
| EBITDA | 125.0 | 96.8 | 142.3 |
| EBITDA Margin (%) | 20.9 % | 18.3 % | 21.7 % |
| Net Profit (PAT) | 93.97 | 55.50 | 117.52 |
| Net Profit Margin (%) | 15.7 % | 10.5 % | 17.9 % |
| EPS (₹) | 7.2 | 4.2 | 9.0 |
Source: Company filings & investor presentations (approximate values)
📈 Revenue Analysis: Monsoon Irregularities Hit Sales
Revenue fell ~9% YoY from ₹ 654 crore to ₹ 598 crore in Q2 FY 2025-26, largely because of:
Uneven monsoon rainfall: Heavy rains in some regions delayed spraying schedules and damaged crops, reducing the need for agrochemicals.
Lower pest infestation: Less pest activity translated into lower pesticide consumption.
Distribution delays: Certain dealers deferred purchases due to unpredictable weather.
Despite this, sequential growth from Q1’s ₹ 528 crore to ₹ 598 crore signals gradual recovery in rural demand, especially in southern and western India.
⚙️ Profitability and Margin Trends
Dhanuka’s PAT slipped 20% YoY to ₹ 93.97 crore versus ₹ 117.52 crore last year. Margins compressed to 15.7% (from 17.9%), reflecting softer volumes and a less favorable product mix.
However, compared to Q1 FY 2025-26, both operating and net margins expanded sharply, driven by:
Better realization in selective herbicides and insecticides.
Improved cost control and working capital management.
Seasonal uptick in Q2 from Kharif demand.
This sequential momentum suggests the company may have bottomed out in Q1 and is now on a recovery path.
🧪 Segment-wise Highlights
1️⃣ Herbicides & Insecticides
These two verticals contribute over 75% of Dhanuka’s total revenue. The herbicide segment under-performed due to delayed sowing and excess rainfall. In contrast, insecticides held steady, supported by product launches in cotton and paddy applications.
2️⃣ Fungicides
Fungicide sales grew marginally as weather conditions increased fungal disease risk in some southern states.
3️⃣ Biologicals & Bio-Stimulants
This segment continues to expand, albeit from a small base (~3% of sales). Management expects this portfolio to reach 5–6% share in the next two years, offering higher margins and environmental compliance benefits.
🏭 Operational and Strategic Updates
Capacity Expansion: The Dahej manufacturing plant is ramping up production of new active ingredients. Trial production of Diniconazole has started, which is expected to add incremental revenue in FY 2026-27.
New Product Launch: The company received registration for Ipf lufenoquin, a novel chemistry developed in collaboration with Nippo Soda, Japan.
Distribution Network: Dhanuka now works with 6,500 distributors and 80,000 retailers across India, ensuring robust rural coverage.
Sustainability Drive: The company continues to invest in eco-friendly formulations and bio-products in line with global ESG standards.
💬 Management Commentary
Mr. M.K. Dhanuka, Managing Director of Dhanuka Agritech Ltd, commented:
“Despite abnormal and uneven rainfall, our Q2 results show operational resilience and prudent cost management. We have maintained profitability and liquidity while continuing to expand our product portfolio. With favorable weather in the second half, we expect improved demand and volume recovery.”
He added:
“Our focus remains on expanding R&D capabilities, launching innovative molecules, and strengthening our presence in emerging agri-markets. The long-term outlook for India’s agriculture sector continues to be robust.”
🔍 Comparison with Previous Quarters
| Metric | Q2 FY 26 vs Q1 FY 26 | Q2 FY 26 vs Q2 FY 25 | Key Driver |
|---|---|---|---|
| Revenue | +13% | −9% | Seasonal recovery after weak Q1 |
| PAT | +69% | −20% | Cost control, but weather impact |
| EBITDA Margin | +260 bps | −80 bps | Better mix, lower fixed cost leverage |
| EPS | +71% | −20% | Sequential profit rebound |
Sequential growth shows clear improvement, while YoY comparison remains affected by base-effect and weather-linked volatility.
📊 Key Financial Ratios
| Ratio | Q2 FY 2025-26 | Q2 FY 2024-25 | Comment |
|---|---|---|---|
| Return on Equity (ROE) | 17.2 % | 20.5 % | Slight dip due to lower PAT |
| Return on Capital Employed (ROCE) | 19.8 % | 22.4 % | Stable operationally |
| Debt-to-Equity | 0.03 | 0.05 | Maintains debt-free balance sheet |
| Interest Coverage | 15.7× | 17.4× | Strong liquidity position |
The company remains fundamentally healthy, with minimal leverage and solid cash reserves.
🧭 Management Guidance for FY 2025-26
Revenue Growth Target: 8–10 % YoY for FY 2025-26, contingent on normal post-monsoon recovery.
EBITDA Margin: To remain between 20–21%, aided by premium product launches.
Capex Plan: ₹ 200 crore for plant modernization and R&D expansion.
New Molecules: 2–3 new products expected to launch by Q4 FY 2025-26.
Export Strategy: Increasing focus on African and Latin American markets.
The management’s tone remains optimistic yet disciplined, signaling confidence in sustainable growth once seasonal headwinds fade.
📉 Stock Market Reaction
After the result announcement, Dhanuka Agritech’s share traded with mild volatility. While short-term investors reacted to the YoY profit decline, long-term analysts see a buying opportunity given Dhanuka’s strong fundamentals, low debt, and expanding product pipeline.
Brokerages maintain a “Hold to Buy” stance, expecting margins to recover by FY 2026-27.
🌱 Industry Outlook
India’s agrochemical sector is poised for steady long-term growth driven by:
Rising farm mechanization and crop intensity.
Government focus on increasing agricultural productivity.
Shift toward environment-friendly bio-solutions.
With its R&D strength, strong brands, and deep distribution, Dhanuka Agritech is well-placed to capture this growth cycle once weather conditions stabilize.
✅ Conclusion
Dhanuka Agritech’s Q2 FY 2025-26 results show short-term pain but long-term promise. The company faced revenue and profit headwinds from erratic monsoon conditions but demonstrated resilience through cost discipline and strategic investments.
As India’s rural economy revives and new products hit the market, Dhanuka Agritech is expected to return to its growth trajectory in the coming quarters. Investors and stakeholders should watch for margin recovery, product launches, and export expansion in the second half of FY 2025-26.
